Full text is available at the source.
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation
Quercetin's protective role against fatty liver caused by high-fat diet in mice linked to balancing gut bacteria and gut-liver communication
AI simplified
Abstract
Quercetin treatment for 16 weeks decreased the NAFLD activity score and insulin resistance in high-fat diet-induced obese mice.
- High-fat diet (HFD) led to obesity, metabolic syndrome, and hepatic steatosis in C57BL/6J mice.
- Increased intrahepatic lipid accumulation was linked to altered gene expression related to lipid metabolism.
- Quercetin supplementation reduced intrahepatic lipid levels by modulating lipid metabolism gene expression and associated lipotoxicity.
- HFD caused dysbiosis characterized by an increased Firmicutes/Bacteroidetes ratio and elevated levels of Gram-negative bacteria.
- Dysbiosis was associated with intestinal barrier dysfunction, endotoxemia, and activation of inflammatory pathways.
- Quercetin treatment reversed gut microbiota imbalance and inflammatory signaling, suggesting potential therapeutic benefits for obesity-related NAFLD.
AI simplified